These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31294507)
1. Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group. Pardo LM; Voigt AP; Alonzo TA; Wilson ER; Gerbing RB; Paine DJ; Dai F; Menssen AJ; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Brodersen LE; Loken MR Cytometry B Clin Cytom; 2020 Jan; 98(1):52-56. PubMed ID: 31294507 [TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity. Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511 [TBL] [Abstract][Full Text] [Related]
3. Utility of CD36 as a novel addition to the immunophenotypic signature of RAM-phenotype acute myeloid leukemia and study of its clinicopathological characteristics. Panda D; Chatterjee G; Sardana R; Khanka T; Ghogale S; Deshpande N; Badrinath Y; Shetty D; Narula G; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR Cytometry B Clin Cytom; 2021 Mar; 100(2):206-217. PubMed ID: 32865882 [TBL] [Abstract][Full Text] [Related]
4. [Immunophenotypic Analysis of Patients with CD56⁺ Acute Myeloid Leukemia]. Guo R; Shen AL; Wang Y; Liu L; Zhang JF; Wang R; Li JY; Wu YJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1231-4. PubMed ID: 26524014 [TBL] [Abstract][Full Text] [Related]
5. Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531. Voigt AP; Brodersen LE; Alonzo TA; Gerbing RB; Menssen AJ; Wilson ER; Kahwash S; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Wells DA; Loken MR Haematologica; 2017 Dec; 102(12):2058-2068. PubMed ID: 28883080 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of CD56 Antigen Expression in Patients with Sun Y; Wan J; Song Q; Luo C; Li X; Luo Y; Huang X; Ding R; Li H; Hou Y; Huang Y; Xie M; Huang Z; Zhang Y; Ma Y; Wu G; Xu S; Chen J Biomed Res Int; 2021; 2021():1929357. PubMed ID: 33928145 [TBL] [Abstract][Full Text] [Related]
8. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group. Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545 [TBL] [Abstract][Full Text] [Related]
10. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes. Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661 [TBL] [Abstract][Full Text] [Related]
11. [Immunophenotype characteristics and prognosis of acute leukemia patients with cross expressing lymphoid and myeloid lineage associated antigens]. Jiang NG; Chen XM; Zhu HL; Zhong L; Zeng TT; Jia YQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1405-9. PubMed ID: 21176339 [TBL] [Abstract][Full Text] [Related]
12. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia. Chen C; Chio CL; Zeng H; Li Y Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945 [TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia. Aref S; Abousamra N; El-Helaly E; Mabed M Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802 [TBL] [Abstract][Full Text] [Related]
14. Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker? Daniels JT; Davis BJ; Houde-McGrail L; Byrd JC Br J Haematol; 1999 Nov; 107(2):381-3. PubMed ID: 10583228 [TBL] [Abstract][Full Text] [Related]
15. The clinical characteristics of CD7+ CD56+ acute myeloid leukemias other than M0. Suzuki R; Ohtake S; Takeuchi J; Nagai M; Kodera Y; Hamaguchi M; Miyawaki S; Karasuno T; Shimodaira S; Ohno R; Nakamura S; Naoe T Int J Hematol; 2010 Mar; 91(2):303-9. PubMed ID: 20111912 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the prognostic value of CD56 in pediatric acute myeloid leukemia. Liang T; Peng Z; Li C; Huang J; Wang H; Bu C; Li J; Zheng Y; Feng X; Li H; Chen C BMC Cancer; 2022 Dec; 22(1):1339. PubMed ID: 36544113 [TBL] [Abstract][Full Text] [Related]
17. CD56 and CD11b Positivity with Low Smac/DIABLO Expression as Predictors of Chemoresistance in Acute Myeloid Leukaemia: Flow Cytometric Analysis. Ibrahim A; Zahran AM; Aly SS; Refaat A; Hassan MH Asian Pac J Cancer Prev; 2018 Nov; 19(11):3187-3192. PubMed ID: 30486609 [TBL] [Abstract][Full Text] [Related]
18. The expression pattern of CD56 (N-CAM) in human bone marrow biopsies infiltrated by acute leukemia. Khanlari B; Buser A; Lugli A; Tichelli A; Dirnhofer S Leuk Lymphoma; 2003 Dec; 44(12):2055-9. PubMed ID: 14959847 [TBL] [Abstract][Full Text] [Related]
19. DHH-RHEBL1 fusion transcript: a novel recurrent feature in the new landscape of pediatric CBFA2T3-GLIS2-positive acute myeloid leukemia. Masetti R; Togni M; Astolfi A; Pigazzi M; Manara E; Indio V; Rizzari C; Rutella S; Basso G; Pession A; Locatelli F Oncotarget; 2013 Oct; 4(10):1712-20. PubMed ID: 24127550 [TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry. Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]